Tel Aviv - Delayed Quote ILA
Ilex Medical Ltd (ILX.TA)
6,052.00
-53.00
(-0.87%)
At close: May 29 at 5:24:56 PM GMT+3
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
920,371
920,371
916,247
863,283
1,060,994
Cost of Revenue
704,060
704,060
689,344
580,373
681,611
Gross Profit
216,311
216,311
226,903
282,910
379,383
Operating Expense
151,587
151,587
149,256
138,088
135,051
Operating Income
64,724
64,724
77,647
144,822
244,332
Net Non Operating Interest Income Expense
4,697
4,697
3,191
-200
-2,187
Pretax Income
61,598
61,598
74,038
143,085
255,346
Tax Provision
15,894
15,894
18,510
34,595
57,866
Net Income Common Stockholders
38,981
38,981
50,885
102,123
197,480
Diluted NI Available to Com Stockholders
38,981
38,981
50,885
102,123
197,480
Basic EPS
3.49
--
4.55
9.05
17.51
Diluted EPS
3.49
--
4.55
9.05
17.50
Basic Average Shares
11,188
--
11,190
11,279
11,281
Diluted Average Shares
11,188
--
11,190
11,279
11,281
Total Operating Income as Reported
66,716
66,716
82,023
165,591
249,950
Rent Expense Supplemental
2,307
2,307
3,698
4,074
6,792
Total Expenses
855,647
855,647
838,600
718,461
816,662
Net Income from Continuing & Discontinued Operation
38,981
38,981
50,885
102,123
197,480
Normalized Income
44,857.41
44,857.41
53,719.77
101,422.63
192,616.20
Interest Income
7,849
7,849
5,736
1,857
600
Interest Expense
2,422
2,422
1,849
1,574
2,012
Net Interest Income
4,697
4,697
3,191
-200
-2,187
EBIT
64,020
64,020
75,887
144,659
257,358
EBITDA
113,118
113,118
123,611
194,698
307,849
Reconciled Cost of Revenue
704,060
704,060
689,344
580,373
681,611
Reconciled Depreciation
49,098
49,098
47,724
50,039
50,491
Net Income from Continuing Operation Net Minority Interest
45,704
45,704
55,528
108,490
197,480
Total Unusual Items Excluding Goodwill
1,141
1,141
2,411
9,321
6,289
Total Unusual Items
1,141
1,141
2,411
9,321
6,289
Normalized EBITDA
111,977
111,977
121,200
185,377
301,560
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
294.41
294.41
602.77
2,253.63
1,425.20
12/31/2021 - 8/12/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade